Method of inhibiting FLT3 kinase

Details for Australian Patent Application No. 2006304897 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Wilson, Kenneth; Chen, Jingsheng; Baumann, Christian Andrew; Tuman, Robert W.; Rudolph, M. Jonathan; Johnson, Dana L.; Illig, Carl R.; Ballentine, Shelley K.; Meegalla, Saneth; Wall, Mark J.

Agent Shelston IP

Pub. Number AU-B-2006304897

PCT Pub. Number WO2007/048088

Priority 60/727,687 18.10.05 US

Filing date 17 October 2006

Wipo publication date 26 April 2007

Acceptance publication date 12 July 2012

International Classifications

A61K 31/4439

A61K 31/454

A61K 31/497

A61K 31/5355 - Non-condensed oxazines containing further heterocyclic rings

A61P 35/00 Antineoplastic agents

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/048088 Priority application(s): WO2007/048088

12 July 2012 Application Accepted

  Published as AU-B-2006304897

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006304898-Multi-plasmid system for the production of influenza virus

2006304895-Canine influenza virus and related compositions and methods of use